Digital mammography is more accurate than film for diagnosis of breast cancer in women with dense breasts, according to results from the Digital Mammographic Imaging Screening Trial presented at the RSNA meeting.
Digital mammography is more accurate than film for diagnosis of breast cancer in women with dense breasts, according to results from the Digital Mammographic Imaging Screening Trial presented at the RSNA meeting.
Dr. Etta Pisano, a professor of radiology at the University of North Carolina, and colleagues, reviewed film and digital mammograms from the DMIST cancer cases and assessed factors contributing to lesion visibility on both modalities. The trial involved 49,529 women from 33 centers.
The researchers sought to understand why digital performed better than film in their analysis of the trial. They found that radiologist readers most frequently attributed differences in cancer visibility to variations in image contrast and not to differences in positioning or compression. Digital showed image contrast much better than film, Pisano said.
Lesion visibility on digital versus film was significantly greater for women with dense breasts even when adjusted for age, lesion type, and mammography system, she said.
For fatty breasts, the researchers found digital and film to be equivalent, with a nonsignificant trend demonstrating film as better in women older than 65. Even with the trend, Pisano does not recommend film screening for women with fatty breasts.
"We have a trend, and frankly given the results of this study, image processing was likely involved in any results that we got. I think the manufacturer should work hard on improving image processing with fatty breasts," she said.
Cancer became more visible on the GE system compared with the Fischer and Fuji products tested, according to the researchers.
Given the accuracy of digital, there is no reason to maintain a film system, Pisano said.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.